Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Levy, A
8 Quick Takes: FDA approves Lillys tirzepatide for weight loss Plus: Takedas fruquintinib approved for colorectal cancer, and updates from Forward, Ascidian, Xencor, UltraDx and more FDAs approval of Zepbound tirzepatide from Eli Lilly and Co
Submit a completed live event evaluation form online within 30 days
These medicines include semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity)
often signal a likely path toward approval in Europe as well
For patients who prefer getting zepbound from Lilly Direct, a $129 one-time onboarding fee will be collected
US$ 28.96
US$ 28.17
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 22.03
US$ 28.20
US$ 20.97
US$ 25.32
US$ 26.28
